Brett Greer

2.5k total citations
68 papers, 2.0k citations indexed

About

Brett Greer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Brett Greer has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Brett Greer's work include Diabetes Treatment and Management (21 papers), Peptidase Inhibition and Analysis (16 papers) and Neuropeptides and Animal Physiology (14 papers). Brett Greer is often cited by papers focused on Diabetes Treatment and Management (21 papers), Peptidase Inhibition and Analysis (16 papers) and Neuropeptides and Animal Physiology (14 papers). Brett Greer collaborates with scholars based in United Kingdom, Thailand and United States. Brett Greer's co-authors include Christopher T. Elliott, Patrick Harriott, Finbarr O’Harte, Peter R. Flatt, Victor A. Gault, Nigel Irwin, Clifford J. Bailey, Julie Meneely, Brian D. Green and G. Brent Irvine and has published in prestigious journals such as Journal of Biological Chemistry, Environmental Science & Technology and Diabetes.

In The Last Decade

Brett Greer

64 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett Greer United Kingdom 30 715 604 435 366 304 68 2.0k
Mark Mooney United Kingdom 24 743 1.0× 674 1.1× 217 0.5× 177 0.5× 194 0.6× 58 1.9k
Motoyuki Shimizu Japan 30 1.5k 2.1× 46 0.1× 118 0.3× 153 0.4× 315 1.0× 96 2.6k
Jung‐Bum Lee Japan 32 666 0.9× 38 0.1× 89 0.2× 133 0.4× 140 0.5× 94 3.0k
Stefano Rufini Italy 23 1.0k 1.4× 61 0.1× 191 0.4× 63 0.2× 208 0.7× 67 1.7k
Robert L. Pollack United States 10 822 1.1× 114 0.2× 175 0.4× 132 0.4× 277 0.9× 22 1.9k
Shoji Odani Japan 38 2.5k 3.5× 59 0.1× 264 0.6× 202 0.6× 285 0.9× 110 3.7k
Jiří Adamec United States 29 2.2k 3.1× 45 0.1× 427 1.0× 57 0.2× 129 0.4× 104 3.5k
Yi Guo China 26 1.9k 2.7× 76 0.1× 142 0.3× 182 0.5× 552 1.8× 66 3.5k
Jiujiu Yu United States 23 2.3k 3.2× 71 0.1× 182 0.4× 239 0.7× 368 1.2× 54 3.7k

Countries citing papers authored by Brett Greer

Since Specialization
Citations

This map shows the geographic impact of Brett Greer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Greer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Greer more than expected).

Fields of papers citing papers by Brett Greer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Greer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Greer. The network helps show where Brett Greer may publish in the future.

Co-authorship network of co-authors of Brett Greer

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Greer. A scholar is included among the top collaborators of Brett Greer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Greer. Brett Greer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Linlin, Li Zhao, Mingshan Li, et al.. (2025). Schizophrenia Treatment Based on Sustained Release of Risperidone from Poly(lactic-co-glycolic) Acid Implantable Microarray Patch. ACS Applied Materials & Interfaces. 17(11). 16616–16631. 2 indexed citations
2.
Pentlavalli, Sreekanth, Sophie Coulter, Emily R. Cross, et al.. (2025). D-peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV prevention. Journal of Controlled Release. 379. 30–44. 5 indexed citations
3.
4.
Naser, Yara A., Qonita Kurnia Anjani, Akmal Hidayat Bin Sabri, et al.. (2024). Dissolving microarray patches for transdermal delivery of risperidone for schizophrenia management. International Journal of Pharmaceutics. 660. 124342–124342. 10 indexed citations
5.
6.
Naser, Yara A., Lalitkumar K. Vora, Ismaiel A. Tekko, et al.. (2024). Atorvastatin-Loaded Dissolving Microarray Patches for Long-Acting Microdepot Delivery: Comparison of Nanoparticle and Microparticle Drug Formulations. ACS Applied Materials & Interfaces. 16(41). 55027–55044. 2 indexed citations
7.
8.
Kolawole, Oluwatobi, Karl De Ruyck, Brett Greer, et al.. (2021). Agronomic Factors Influencing the Scale of Fusarium Mycotoxin Contamination of Oats. Journal of Fungi. 7(11). 965–965. 14 indexed citations
9.
Greer, Brett, Ronald Maul, Katrina Campbell, & Christopher T. Elliott. (2017). Detection of freshwater cyanotoxins and measurement of masked microcystins in tilapia from Southeast Asian aquaculture farms. Analytical and Bioanalytical Chemistry. 409(16). 4057–4069. 49 indexed citations
10.
Meneely, Julie, Olivier Chevallier, Stewart F. Graham, et al.. (2016). β-methylamino-L-alanine (BMAA) is not found in the brains of patients with confirmed Alzheimer’s disease. Scientific Reports. 6(1). 36363–36363. 27 indexed citations
11.
Elliott, Sarah, et al.. (2008). IQ motif selectivity in human IQGAP1: binding of myosin essential light chain and S100B. Molecular and Cellular Biochemistry. 318(1-2). 43–51. 18 indexed citations
12.
O’Harte, Finbarr, Kerry Hunter, Victor A. Gault, et al.. (2007). Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabeticob/obmice. American Journal of Physiology-Endocrinology and Metabolism. 292(6). E1674–E1682. 10 indexed citations
13.
Gault, Victor A., Kerry Hunter, Nigel Irwin, et al.. (2007). Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes. Biological Chemistry. 388(2). 173–9. 14 indexed citations
14.
Mattice, John D., Edward E. Gbur, Brett Greer, & B. W. Skulman. (2007). A Mobile Field Extractor for Extracting Water Samples While Driving between Sampling Sites. Bulletin of Environmental Contamination and Toxicology. 78(1). 59–62. 1 indexed citations
15.
Irwin, Nigel, Brian D. Green, Brett Greer, et al.. (2006). Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide. Biochemical Pharmacology. 72(6). 719–728. 34 indexed citations
16.
Green, BD, Victor A. Gault, MH Mooney, et al.. (2004). Molecular, cellular and biological characteristics of DPP IV-resistant acetylated analogues of GLP-1.. Diabetic Medicine. 21. 26–26. 1 indexed citations
17.
Bodles, Angela M., Omar M. A. El‐Agnaf, Brett Greer, David J. S. Guthrie, & G. Brent Irvine. (2004). Inhibition of fibril formation and toxicity of a fragment of α-synuclein by an N-methylated peptide analogue. Neuroscience Letters. 359(1-2). 89–93. 53 indexed citations
18.
Green, BD, MH Mooney, Victor A. Gault, et al.. (2004). N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity. Journal of Endocrinology. 180(3). 379–388. 50 indexed citations
19.
Green, BD, Victor A. Gault, Nigel Irwin, et al.. (2003). Metabolic Stability, Receptor Binding, cAMP Generation, Insulin Secretion and Antihyperglycaemic Activity of Novel N-Terminal Glu9-Substituted Analogues of Glucagon-Like Peptide-1. Biological Chemistry. 384(12). 1543–51. 23 indexed citations
20.
Stitt, Alan W., et al.. (2002). Synthetic Peptides Interacting with the 67-kd Laminin Receptor Can Reduce Retinal Ischemia and Inhibit Hypoxia-Induced Retinal Neovascularization. American Journal Of Pathology. 160(1). 307–313. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Mooney Breakdown of academic impact, for papers by Motoyuki Shimizu Breakdown of academic impact, for papers by Jung‐Bum Lee Breakdown of academic impact, for papers by Stefano Rufini Breakdown of academic impact, for papers by Robert L. Pollack Breakdown of academic impact, for papers by Shoji Odani Breakdown of academic impact, for papers by Jiří Adamec Breakdown of academic impact, for papers by Yi Guo Breakdown of academic impact, for papers by Jiujiu Yu
Rankless by CCL
2026